BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 33728811)

  • 1. Risk of cardiac-related mortality in stage IIIA-N2 non-small cell lung cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) database.
    Sun X; Men Y; Wang J; Bao Y; Yang X; Zhao M; Sun S; Yuan M; Ma Z; Hui Z
    Thorac Cancer; 2021 May; 12(9):1358-1365. PubMed ID: 33728811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient prognostic scores and association with survival improvement offered by postoperative radiotherapy for resected IIIA/N2 non-small cell lung cancer: A population-based study.
    Xu L; Xie HN; Chen XK; Bi N; Qin JJ; Li Y
    Thorac Cancer; 2021 Mar; 12(6):760-767. PubMed ID: 33481353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between postoperative radiotherapy for young-onset non-small cell lung cancer and risk of second primary malignancies ----Comparative study.
    Li Z; Guo M; Liu L; Deng S
    Int J Surg; 2024 May; ():. PubMed ID: 38716897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respiratory and Cardiometabolic Comorbidities and Stages I to III NSCLC Survival: A Pooled Analysis From the International Lung Cancer Consortium.
    García-Pardo M; Chang A; Schmid S; Dong M; Brown MC; Christiani D; Tindel HA; Brennan P; Chen C; Zhang J; Ryan BM; Zaridze D; Schabath MB; Leal LF; Reis RM; Tardon A; Fernández-Tardon G; Shete SS; Andrew A; Brenner H; Xu W; Hung RJ; Liu G
    J Thorac Oncol; 2023 Mar; 18(3):313-323. PubMed ID: 36396063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-to-Progression of NSCLC from Early to Advanced Stages: An Analysis of data from SEER Registry and a Single Institute.
    Yuan P; Cao JL; Rustam A; Zhang C; Yuan XS; Bao FC; Lv W; Hu J
    Sci Rep; 2016 Jun; 6():28477. PubMed ID: 27346236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risks and trends of cardiac-specific mortality associated with chemotherapy or radiotherapy in a large cohort of non-elderly patients with non-small cell lung cancer.
    Jiang KT; Huang DZ
    Transl Cancer Res; 2021 Feb; 10(2):842-853. PubMed ID: 35116414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The reliability and validity of lung cancer and melanoma clinical quality survival measures.
    Pendl-Robinson E; Calkins KL; Simon SE; Barrett K; Poznyak D
    Health Serv Res; 2023 Oct; 58(5):1131-1140. PubMed ID: 37669902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors for Cardiovascular-Specific Mortality in Patients With Prostate Cancer: A Surveillance, Epidemiology, and End Results (SEER)-Based Study.
    Alhadeethi A; Atia A; Alkhawaldeh IM; Ibrahim AA; Afifi E; Elwekel A; Nouh A; Morsi MH
    Cureus; 2023 Dec; 15(12):e51279. PubMed ID: 38288190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain and heart-specific death in cancer patients: Population-based study.
    Safi M; Al-Nusaif M; Trapani D; Mashrah MA; Kanesvaran R; Alzandani A; Al-Azab M; Mazher SA; Al-Danakh A; Liu J
    Cancer Med; 2021 Sep; 10(17):5739-5747. PubMed ID: 34374226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overall Survival in Heart Disease-Related Death in Non-Small Cell Lung Cancer Patients: Nonimmunotherapy Versus Immunotherapy Era: Population-Based Study.
    Safi M; Kanesvaran R; Alradhi M; Al-Danakh A; Ping F; Al-Sabai N; Shan X; Liu J
    Front Oncol; 2020; 10():572380. PubMed ID: 33194672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular mortality among patients with diffuse large B-cell lymphoma: a population-based study.
    Hong D; Yin M; Li J; Deng Z; Ren Z; Zhou Y; Huang S; Yan X; Zhong W; Liu F; Yang C
    Leuk Lymphoma; 2024 Jun; ():1-11. PubMed ID: 38861618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cardiac effects of postoperative radiotherapy in patients with non-small cell lung cancer warrants further evaluation.
    Ma Z; Liu Q; Hui Z
    Radiother Oncol; 2024 Jul; 196():110315. PubMed ID: 38688359
    [No Abstract]   [Full Text] [Related]  

  • 13. A Prognostic Nomogram of Colon Cancer With Liver Metastasis: A Study of the US SEER Database and a Chinese Cohort.
    Liu C; Hu C; Huang J; Xiang K; Li Z; Qu J; Chen Y; Yang B; Qu X; Liu Y; Zhang G; Wen T
    Front Oncol; 2021; 11():591009. PubMed ID: 33738248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic index for estimating the survival benefit of postoperative radiotherapy in pathologic N2 non-small cell lung cancer: A real-world validation study.
    Zhang CC; Hou RP; Xia WY; Zeng WQ; Liu J; Wang JM; Lv CX; Luo QQ; Zhao H; Yu W; Zhang Q; Zhu ZF; Cai XW; Feng W; Fu XL
    Lung Cancer; 2021 Jun; 156():100-108. PubMed ID: 33940542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: a preferential benefit for squamous cell carcinoma.
    Tian C; Liu G; Xu Y; Xia G; Zhang T; Huang J; Jiang H; Ming Wang J; Li B
    Radiol Oncol; 2020 Dec; 55(1):66-76. PubMed ID: 33885242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Clinical Nomogram for Predicting Lymph Node Metastasis in Penile Cancer: A SEER-Based Study.
    Zhang W; Gao P; Gao J; Wu X; Liu G; Zhang X
    Front Oncol; 2021; 11():640036. PubMed ID: 33768001
    [No Abstract]   [Full Text] [Related]  

  • 17. [Survival benefit of primary site surgery acquired by stage Ⅳ non-small cell lung cancer: a retrospective study based on seer database].
    Li L; Xu B; Wu J; Song QB
    Zhonghua Zhong Liu Za Zhi; 2021 Mar; 43(3):335-344. PubMed ID: 33752315
    [No Abstract]   [Full Text] [Related]  

  • 18. Establishment and validation of a novel nomogram to predict overall survival in nasopharyngeal carcinoma with lymph node metastasis.
    Li W; Lu H; Wang H; Hu L; Sun X; Yu H; Wang D
    Head Neck; 2021 Aug; 43(8):2353-2363. PubMed ID: 33780078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy in the Era of Immunotherapy With a Focus on Non-Small-Cell Lung Cancer: Time to Revisit Ancient Dogmas?
    Khalifa J; Mazieres J; Gomez-Roca C; Ayyoub M; Moyal EC
    Front Oncol; 2021; 11():662236. PubMed ID: 33968769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Prognostic Risk Stratification Model to Identify Potential Population Benefiting From Postmastectomy Radiotherapy in T1-2 Breast Cancer With 1-3 Positive Axillary Lymph Nodes.
    Hou N; Zhang J; Yang L; Wu Y; Wang Z; Zhang M; Yang L; Hou G; Wu J; Wang Y; Dong B; Guo L; Shi M; Ling R
    Front Oncol; 2021; 11():640268. PubMed ID: 33954110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.